Financhill
Back

ASLAN Pharmaceuticals Quote, Financials, Valuation and Earnings

ASLAN Pharmaceuticals Price Quote

$0.52
0.00 (-3.7%)
(Updated: April 20, 2024 at 6:04 AM ET)

ASLAN Pharmaceuticals Key Stats

Sell
42
ASLAN Pharmaceuticals (ASLN) is a Sell

Day range:
$0.50 - $0.57
52-week range:
$0.39 - $4.69
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
0.00
P/B ratio:
0%

Volume:
25.5K
Avg. volume:
1.9M
1-year change:
-86.65%
Market cap:
$11.8M
Revenue:
$12M
EPS:
$-2.61

How Much Does ASLAN Pharmaceuticals Make?

Data Unavailable

Is ASLAN Pharmaceuticals Growing As A Company?

Data Unavailable

ASLAN Pharmaceuticals Stock Price Performance

What Is ASLAN Pharmaceuticals 52-Week High & Low?

ASLAN Pharmaceuticals Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy ASLAN Pharmaceuticals?

Is ASLAN Pharmaceuticals Cash Flow Positive?

Data Unavailable

ASLAN Pharmaceuticals Return On Invested Capital

Data Unavailable

ASLAN Pharmaceuticals Earnings Date & Stock Price

ASLAN Pharmaceuticals Competitors

  • Who Are ASLAN Pharmaceuticals's Competitors?
    Below is a list of companies who compete with ASLAN Pharmaceuticals or are related in some way:
    • Concord Medical Services Holdings Ltd (CCM)
    • CytoMed Therapeutics Ltd (GDTC)
    • Dr Reddy's Laboratories Ltd (RDY)
    • WAVE Life Sciences Ltd (WVE)
    • Zai Lab Ltd (ZLAB)

ASLAN Pharmaceuticals Dividend Yield

Data Unavailable

ASLAN Pharmaceuticals Analyst Estimates

YoY Growth Past Surprise
EPS: 0% -21.54%
Revenue: 0% 0%

Analyst Recommendations

Buy Recommendations: 0
Hold Recommendations: 0
Sell Recommendations: 0
Price Target: 9.50
Upside from Last Price: 1724.82%

Major Shareholders

  • How many ASLN shares are owned by institutional investors?
    43.9M ASLN shares are owned by institutional investors
  • How many ASLN shares are owned by insiders?
    0 ASLN shares are owned by insiders